Vor Biopharma (VOR)

• Market cap: $677M
• 1 day: -3.35%
• 5 days: 0.22%
• 1 month: -20.36%
• 3 months: 8.29%
• 6 months: -38.2%
• Year to date: 18.99%
• 1 year: 4.77%
• 5 years: -97.61%
• 10 years: -98.15%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Employees: 168